Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Filgrastim-SD/01 with Docetaxel and Gemcitabine in Advanced NSCLC
NCT00050674Phase 2Completed
- Start
- Nov 2001
- Primary completion
- Feb 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of pegfilgrastim in neutropenia. Started Nov 2001; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00050674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00050674.